Compared with other established glioma markers (including GFAP, p53 and WT1) IDH1 has been shown to have high specificity and sensitivity in differentiating reactive gliosis from neoplastic cells and even detected a single infiltrating tumour cell at the infiltrating edge of the gliomas [1–3]. Here, IDH1 is linked to neoplasm.